|The KLK13 klk13 (Catalog #MBS2528297) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The KLK13 Polyclonal Antibody reacts with H and may cross-react with other species as described in the data sheet. MyBioSource\'s KLK13 can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Immunohistochemistry (IHC).
IHC: 1:25-1:100. Researchers should empirically determine the suitability of the KLK13 klk13 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The KLK13 klk13 product has the following accession number(s) (GI #11496281) (NCBI Accession #NP_056411.1) (Uniprot Accession #BC069334). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the KLK13 Polyclonal Antibody with the following immunoassay(s):
Immunohistochemistry (IHC) (Immunohistochemistry of paraffin-embedded Human brain tissue using KLK13 Polyclonal Antibody at dilution 1:20)
Immunohistochemistry (IHC) (Immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using KLK13 Polyclonal Antibody at dilution 1:20)
Background: Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Expression of this gene is regulated by steroid hormones and may be useful as a marker for breast cancer. An additional transcript variant has been identified, but its full length sequence has not been determined.
In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing KLK13 are readily searchable from our website. Different antibodies against the same target such as KLK13 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Breast Neoplasms, Carcinoma, Squamous Cell, Death, Infertility, Male, Inflammation, Lung Neoplasms, Necrosis, Neoplasms, Experimental, Ovarian Diseases, Psoriasis are some of the diseases may be linked to KLK13 Polyclonal Antibody. Mouth, Testis, Uncharacterized Tissue tissues are correlated with this protein. KLK13 also interacts with the following gene(s): A2M. The following patways have been known to be associated with this gene.